Patent assignee · FR · COMPANY

Xenothera

1Patents
1Active
1Granted
37Portfolio score

Filing activity: Oct 15, 2015 → Oct 15, 2015

Most-cited patents

PatentTitleAreaCited byStatus
US11725044B2 Method for producing polyclonal antibodies with improved complement-dependent cytotoxicity Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.